Based on MarketsandMarkets™ report "Cardiac Monitoring & Cardiac Rhythm Management Devices Market By Product, CM (ECG (Holter Monitor), ILR, Event Monitor)), CRM ((Defibrillator (ICD) External (AED)), Pacemaker (CRT P, Dual Chamber Pacemaker)), End User & Region – Global Forecast to 2025" The Global Cardiac Monitoring & Cardiac Rhythm Management Devices Market is projected to reach USD 26.8 billion by 2025 from USD 22.1 billion in 2020, at a CAGR of 4.0% from 2020 to 2025.

Download PDF Brochure:
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=55

Browse
• 336 market data Tables
• 40 Figures
• 266 Pages and in-depth TOC on "Cardiac Monitoring & Cardiac Rhythm Management Devices Market - Global Forecast to 2025"

Some of the prominent key players are:
Medtronic (Ireland),
Boston Scientific (US),
Abbott Laboratories (US),
GE Healthcare (US),
BIOTRONIK (Germany),
Koninklijke Philips (Netherlands),
Asahi Kasei Corporation (Japan),
MicroPort Scientific Corporation (China),
Hill-Rom Holdings (US),
Nihon Kohden (Japan),
SCHILLER AG (Switzerland) and many more.........
The growth of this market is driven by the increasing prevalence of cardiovascular diseases; availability of reimbursement for CM & CRM devices; launch of innovative products by market players; increasing investments, funds, and grants for research on CM & CRM devices; and the growing preference for wearable cardiac devices.

“ECG Devices is expected to hold the largest share of the cardiac monitoring devices market in 2020”

On the basis of cardiac monitoring devices by type, the market is segmented into ECG devices, event monitors, implantable loop recorders (ILRs), cardiac output monitoring (COM) devices, mobile cardiac telemetry (MCT) devices, and smart ECG monitors. In 2019, the ECG devices segment accounted for the largest share of the cardiac monitoring devices market. The large share of this segment can be attributed to technological advancements such as the incorporation of advanced algorithms and workflow improvement features, such as simplified operations, touchscreen systems, portability, wireless features, and better connectivity with cardiovascular information systems (CVIS), electronic medical records (EMRs), and ECG management systems.

Request Sample Pages:
https://www.marketsandmarkets.com/requestsampleNew.asp?id=55

“North America commanded the largest share of the cardiac monitoring & cardiac rhythm management devices market in 2020.”

On the basis of region, the cardiac monitoring & cardiac rhythm management devices market is segmented into North America, Europe, Asia Pacific, and Rest of the World. In 2019, North America commanded the largest share of the cardiac monitoring & cardiac rhythm management devices market. The large share of this market segment can be attributed to the increasing incidence of CVD, increasing healthcare expenditure, growing disposable income, growing healthcare awareness, and the availability of technologically advanced devices in the region.

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Markets and Markets’s flagship competitive intelligence and market research platform, "Knowledge Store" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.